How often does Crinetics Pharmaceuticals move more than the options market prices?

1 of the last 8 reports moved at least as far as the implied move.

CRNXNasdaqPharmaceutical Preparations

Crinetics Pharmaceuticals, Inc. (CRNX) earnings date, market-implied expected move, and options open interest by expiry

84.97

+0.13 · +0.15%

post 84.97 0.00%

Closed19:15 ET

Open84.92Volume8.2MMkt cap$509.7MEPS-5.05

Day84.92 – 85.0066%52-wk31.00 – 85.01100%

CRNX

Crinetics Pharmaceuticals, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

News

Next report

Last report

+0.12%

vs ±1.1% implied · ×0.11

shaded = implied · ▲▼ = realized

Aug 3 '26 · confirmed

Implied vs realized

Largest filed tie

—

13F top-10 QoQ

+4.06%

shares held · 10 largest managers

13F · Jun 30 '26129d lag

261 managers

Top fund weight

2.01%

CRNX weight · EVNT

N-PORTAug 31 '26

5 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Crinetics Pharmaceuticals (CRNX) is expected to report on Nov 12 after close (estimated date).

Implied vs realized

8 reports

1 of 8≥ implied

avg implied: ±9.2%
avg realized: ±6.3%

Feb 27 '25Feb 27 '25confirmed±11.0%▲+7.74%×0.70

May 8 '25May 8 '25confirmed±8.8%▼−6.18%×0.70

Aug 7 '25Aug 7 '25confirmed±10.4%▼−3.69%×0.35

Nov 6 '25Nov 6 '25confirmed±10.1%▼−8.02%×0.79

Jan 5 '26Jan 5 '26confirmed±10.1%▼−4.63%×0.46

Q1 FY26Feb 26 '26confirmed±12.4%▼−6.04%×0.49

May 7 '26May 7 '26confirmed±9.5%▼−13.82%×1.45

Q2 FY26Aug 3 '26confirmed±1.1%▲+0.12%×0.11

quarterimplied−15%0+15%realized×

Q2 FY26±1.1%▲+0.12%×0.11

May '26±9.5%▼−13.82%×1.45

Q1 FY26±12.4%▼−6.04%×0.49

Jan '26±10.1%▼−4.63%×0.46

Nov '25±10.1%▼−8.02%×0.79

Aug '25±10.4%▼−3.69%×0.35

2 older reports

May '25±8.8%▼−6.18%×0.70

Feb '25±11.0%▲+7.74%×0.70

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 1 expiry · Sep 7 close

0.04OI · 1 expiry · Sep 7 closeP/C open interest · Dec 18 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

4470%Dec 1842d12,3110%

ExpiryPutsCallsP/C

Dec 1842d4470%12,3110%0.04

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−481.15%as filednet margin · revenue +134.00% QoQ · +2336.28% YoY

Revenue$25M+134.00%

Gross profit$25M99.39%+136.99%

Operating income−$132M−527.35%+5.64%

Pre-tax income−$121M+5.47%

Net income−$121M−481.15%+5.47%

Cost of revenue$154,000−23.00%

Operating expenses$157M+4.31%

Other income$12M−7.41%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 19:15 ET

Intraday

Event sensitivity

NFP ×1.64· ±3.9% vs ±2.4% · 8 releases

eventrelease day|move|up · n×base

NFPjobs report±3.9%3 of 8×1.64

PCEpersonal income & outlays±2.9%7 of 18×1.23

PPIproducer prices±2.6%4 of 9×1.10

FOMCrate decision±1.9%16 of 23×0.79

CPIconsumer prices±1.6%3 of 9×0.69

CPROFcorporate profits±1.4%4 of 11×0.58

GDPgross domestic product±1.3%9 of 18×0.56

Bar = avg |move| to ±4% · tick = ±2.4% avg day · ×base = |move| ÷ ±2.4% · min 6 releases

Earnings history

EPS -1.14 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 3 '26 · confirmed	-1.14	—
Q1 FY26	Feb 26 '26 · confirmed	-1.23	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod